Endoscopy devices are medical devices used to examine internal organs for diagnosis of diseases. Endoscopic Hemostasis devices consists of devices employed in the management of Gastrointestinal (GI) bleeding and often acts as the first line of therapy. GlobalData uses proprietary data and analytics to provide a comprehensive report on the endoscopic hemostasis devices market in China. Buy the latest report here.

In 2022, GlobalData’s Market Model methodology determined that the leading player in the endoscopic hemostasis devices market in China was Boston Scientific followed by ConMed, Cook Medical, Diversatek, ERBE Elektromedizin, Integra LifeSciences, Medline Industries, Micro-Tech Nanjing, Olympus and United States Endoscopy Group.

Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.

Endoscopic Hemostasis devices are generally classified into mechanical devices (clips, ligation devices, suturing devices, stents), injection devices (injection needles), thermal devices (hemostatic probes, hemostatic forceps, heater probe, argon plasma coagulation, radiofrequency ablation, and cryotherapy) and topical devices (hemostatic spray).

The endoscopic hemostasis devices market in China can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.

For the latest analysis of the market size endoscopic hemostasis devices in China, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.